Hétérogénéité des tumeurs : l’apport du séquençage sur cellules individuelles - Chroniques génomiques

Bertrand Jordan

doi:10.1051/medsci/20143012023

Accueil

Tous les numéros

Volume 30 / Numéro 12 (Décembre 2014)

Med Sci (Paris), 30 12 (2014) 1184-1186

Références

Accès gratuit

Numéro		Med Sci (Paris) Volume 30, Numéro 12, Décembre 2014


Page(s)		1184 - 1186
Section		Forum
DOI		https://doi.org/10.1051/medsci/20143012023
Publié en ligne		24 décembre 2014

Saunders NA, Simpson F, Thompson EW, et al. Role of intratumoural heterogeneity in cancer drug resistance: molecular and clinical perspectives. EMBO Mol Med 2012 ; 4 : 675–684. [CrossRef] [PubMed] [Google Scholar]
Zong C, Lu S., Chapma, AR, Xie XS. Genome-wide detection of single nucleotide and copy-number variations of a single human cell. Science 2012 ; 338 : 1622–1626. [CrossRef] [PubMed] [Google Scholar]
Navin, N. Kendall J, Troge J, et al. Tumour evolution inferred by single-cell sequencing. Nature 2011 ; 472 : 90–94. [CrossRef] [PubMed] [Google Scholar]
Wang Y, Waters J, Leung ML, et al. Clonal evolution in breast cancer revealed by single nucleus genome sequencing. Nature 2014 ; 512 : 155–160. [CrossRef] [PubMed] [Google Scholar]
Hou, Y. Song L, Zhu P, et al. Single-cell exome sequencing and monoclonal evolution of a JAK2-negative myeloproliferative neoplasm. Cell 2012 ; 148 : 873–885. [CrossRef] [PubMed] [Google Scholar]
Schmitt, M. W. Kennedy SR, Salk JJ, et al. Detection of ultra-rare mutations by next-generation sequencing. Proc Natl Acad Sci USA 2012 ; 109 : 14508–14513. [CrossRef] [Google Scholar]
De Bruin EC, McGranahan N, Mitter R, et al. Spatial and temporal diversity in genomic instability processes defines lung cancer evolution. Science 2014 ; 346 : 251–256. [CrossRef] [PubMed] [Google Scholar]
Zhang J, Fujimoto J, Zhang J, et al. Intratumor heterogeneity in localized lung adenocarcinomas delineated by multiregion sequencing. Science 2014 ; 346 : 256–259. [CrossRef] [PubMed] [Google Scholar]
Rosenberg SA. Decade in review-cancer immunotherapy: Entering the mainstream of cancer treatment. Nature Rev Clin Onc 2014 ; 11 : 630–632. [CrossRef] [Google Scholar]
Hait WN, Levine AJ. Genomic complexity: a call to action. Sci Transl Med 2014 ; 6 : 255cm10. [CrossRef] [PubMed] [Google Scholar]
Esserman LJ, Thompson IM, Jr, Reid B. Overdiagnosis and overtreatment in cancer: an opportunity for improvement. JAMA 2013 ; 310 : 797–798. [CrossRef] [PubMed] [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.

[1] Saunders NA, Simpson F, Thompson EW, et al. Role of intratumoural heterogeneity in cancer drug resistance: molecular and clinical perspectives. EMBO Mol Med 2012 ; 4 : 675–684. [CrossRef] [PubMed] [Google Scholar]

[2] Zong C, Lu S., Chapma, AR, Xie XS. Genome-wide detection of single nucleotide and copy-number variations of a single human cell. Science 2012 ; 338 : 1622–1626. [CrossRef] [PubMed] [Google Scholar]

[3] Navin, N. Kendall J, Troge J, et al. Tumour evolution inferred by single-cell sequencing. Nature 2011 ; 472 : 90–94. [CrossRef] [PubMed] [Google Scholar]

[4] Wang Y, Waters J, Leung ML, et al. Clonal evolution in breast cancer revealed by single nucleus genome sequencing. Nature 2014 ; 512 : 155–160. [CrossRef] [PubMed] [Google Scholar]

[5] Hou, Y. Song L, Zhu P, et al. Single-cell exome sequencing and monoclonal evolution of a JAK2-negative myeloproliferative neoplasm. Cell 2012 ; 148 : 873–885. [CrossRef] [PubMed] [Google Scholar]

[6] Schmitt, M. W. Kennedy SR, Salk JJ, et al. Detection of ultra-rare mutations by next-generation sequencing. Proc Natl Acad Sci USA 2012 ; 109 : 14508–14513. [CrossRef] [Google Scholar]

[7] De Bruin EC, McGranahan N, Mitter R, et al. Spatial and temporal diversity in genomic instability processes defines lung cancer evolution. Science 2014 ; 346 : 251–256. [CrossRef] [PubMed] [Google Scholar]

[8] Zhang J, Fujimoto J, Zhang J, et al. Intratumor heterogeneity in localized lung adenocarcinomas delineated by multiregion sequencing. Science 2014 ; 346 : 256–259. [CrossRef] [PubMed] [Google Scholar]

[9] Rosenberg SA. Decade in review-cancer immunotherapy: Entering the mainstream of cancer treatment. Nature Rev Clin Onc 2014 ; 11 : 630–632. [CrossRef] [Google Scholar]

[10] Hait WN, Levine AJ. Genomic complexity: a call to action. Sci Transl Med 2014 ; 6 : 255cm10. [CrossRef] [PubMed] [Google Scholar]

[11] Esserman LJ, Thompson IM, Jr, Reid B. Overdiagnosis and overtreatment in cancer: an opportunity for improvement. JAMA 2013 ; 310 : 797–798. [CrossRef] [PubMed] [Google Scholar]